You areYou are right i think,
The purpose of these cohorts is to check for toxicity. My understanding of why the same people who have already been cured are still being used is i think becuase T-cell theraphy is a person specific engineered therapy. so it would be more cost effective and ethical to continue treating the same patients you have already created a dose of your product for if all you are trying to work out is if there is toxicity at larger doses.
but i could be wrong.
If they are then working out efficacy of the product then new people will be enrolled.
- Forums
- ASX - By Stock
- Ann: PTX-200 AML Trial Progresses to Higher Dose
PTX
prescient therapeutics limited
Add to My Watchlist
0.00%
!
4.3¢

You areYou are right i think,The purpose of these cohorts is to...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 109846 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 113296 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 237968 | 0.043 |
2 | 228893 | 0.042 |
6 | 260184 | 0.041 |
9 | 944948 | 0.040 |
2 | 30000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 60000 | 1 |
0.049 | 157968 | 1 |
0.050 | 454998 | 3 |
0.051 | 270000 | 2 |
0.052 | 68692 | 2 |
Last trade - 09.18am 04/04/2025 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
Day chart unavailable
The Watchlist
AUK
AUMAKE LIMITED.
CEO Hai Yun Chen, Non-Executive Chairman Anthony Noble
CEO Hai Yun Chen
Non-Executive Chairman Anthony Noble
SPONSORED BY The Market Online